This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Patrys Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Frank Schoenen: Innovator in Antibody Development
Introduction
Frank Schoenen is a notable inventor based in Wurzburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Frank Schoenen holds a patent for "LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same." This invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid, and other compositions. The patent outlines methods for using these antibodies in treating metastasis of neoplasia, tumors, or cancer. By administering LM-1 antibodies or functional fragments, effective treatment options are available for patients in need.
Career Highlights
Frank Schoenen is associated with Patrys Limited, a company dedicated to advancing antibody-based therapies. His work has been instrumental in developing innovative treatments that leverage the body's immune response to combat cancer. With a focus on research and development, he continues to push the boundaries of what is possible in medical science.
Collaborations
Frank collaborates with talented individuals such as Leodevico Luna Ilag and Stephanie Ute Brandlein. Together, they work towards enhancing the efficacy of antibody therapies and exploring new avenues for treatment.
Conclusion
Frank Schoenen's contributions to the field of biotechnology, particularly through his patent on LM-1 antibodies, highlight his role as an innovator in medical science. His work not only advances therapeutic options but also paves the way for future research in cancer treatment.